JBMR plus

Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone.

JBMR plus

Lung H, Wentworth KL, Moody T, Zamarioli A, Ram A, Ganesh G, Kang M, Ho S, Hsiao EC

Wnt Pathway Inhibition with the Porcupine Inhibitor LGK974 Decreases Trabecular Bone but not Fibrosis in a Murine Model with Fibrotic Bone.

JBMR plus

Hsuan Lung, Kelly L Wentworth, Tania Moody, Ariane Zamarioli, Apsara Ram, Gauri Ganesh, Misun Kang, Sunita Ho, Edward C Hsiao

Burosumab versus conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.

JBMR plus

Leanne M Ward, Wolfgang Högler, Francis H Glorieux, Anthony A Portale, Michael P Whyte, Craig F Munns, Ola Nilsson, Jill H Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Etienne Sochett, Koji Muroya, Hiroyuki Tanaka, Pisit Pitukcheewanont, Gary S Gottesman, Andrew Biggin, Farzana Perwad, Angel Chen, J Lawrence Merritt, Erik A Imel

Introduction: Special Issue on Vitamin D Dedicated to the Memory of Anthony W Norman.

JBMR plus

Bouillon R, Haussler M, Bikle D, Christakos S, Welsh J

Erratum for Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.

JBMR plus

Dhaliwal R, Hans D, Hattersley G, Mitlak B, Fitzpatrick LA, Wang Y, Schwartz AV, Miller PD, Josse RG

Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.

JBMR plus

Dhaliwal R, Hans D, Hattersley G, Mitlak B, Fitzpatrick LA, Wang Y, Schwartz AV, Miller PD, Josse RG

Commercial Laboratory Reproducibility of Serum CTX in Clinical Practice.

JBMR plus

Hindi SM, Vittinghoff E, Schafer AL, Silverman S, Bauer DC

Pages